Nicola D. Roberts

ORCID: 0000-0002-0469-1043
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Genomics and Chromatin Dynamics
  • Genomic variations and chromosomal abnormalities
  • Chromosomal and Genetic Variations
  • Genomics and Phylogenetic Studies
  • Evolution and Genetic Dynamics
  • Bioinformatics and Genomic Networks
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • DNA Repair Mechanisms
  • Chronic Lymphocytic Leukemia Research
  • Cancer-related molecular mechanisms research
  • Genetic Associations and Epidemiology
  • Cancer-related gene regulation
  • Chronic Myeloid Leukemia Treatments
  • Genomics and Rare Diseases
  • Nutrition, Genetics, and Disease
  • Lung Cancer Treatments and Mutations
  • Mitochondrial Function and Pathology
  • RNA Research and Splicing
  • Plant Disease Resistance and Genetics
  • Telomeres, Telomerase, and Senescence
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer, Hypoxia, and Metabolism

Wellcome Sanger Institute
2016-2023

University of Cambridge
2014-2023

Mayo Clinic in Arizona
2020

Addenbrooke's Hospital
2015

Centre for Cancer Biology
2013-2014

South Australia Pathology
2013-2014

The University of Adelaide
2013

University of Bradford
1980

Recent studies have provided a detailed census of genes that are mutated in acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity defines the pathophysiology AML and informs clinical practice.

10.1056/nejmoa1516192 article EN New England Journal of Medicine 2016-06-08
Yilong Li Nicola D. Roberts Jeremiah A. Wala Ofer Shapira Steven E. Schumacher and 95 more Kiran Kumar Ekta Khurana Sebastian M. Waszak Jan O. Korbel James E. Haber Marcin Imieliński Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martínez-Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nikos Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Joachim Weischenfeldt Rameen Beroukhim Peter J. Campbell Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour

Abstract A key mutational process in cancer is structural variation, which rearrangements delete, amplify or reorder genomic segments that range size from kilobases to whole chromosomes 1–7 . Here we develop methods group, classify and describe somatic variants, using data the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium International Cancer Genome (ICGC) The Atlas (TCGA), aggregated whole-genome sequencing 2,658 cancers across 38 tumour types 8 Sixteen signatures variation...

10.1038/s41586-019-1913-9 article EN cc-by Nature 2020-02-05
Isidro Cortés‐Ciriano Jake June-Koo Lee Ruibin Xi Dhawal Jain Youngsook L. Jung and 95 more Lixing Yang Dmitry A. Gordenin Leszek J. Klimczak Cheng‐Zhong Zhang David Pellman Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martínez-Fundichely Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nicholas D. Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Peter J. Park Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour Malik Alawi Monique Albert Kenneth Aldape Ludmil B. Alexandrov

Chromothripsis is a mutational phenomenon characterized by massive, clustered genomic rearrangements that occurs in cancer and other diseases. Recent studies selected types have suggested chromothripsis may be more common than initially inferred from low-resolution copy-number data. Here, as part of the Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium International Cancer Genome (ICGC) The Atlas (TCGA), we analyze patterns across 2,658 tumors 38 using whole-genome sequencing We find...

10.1038/s41588-019-0576-7 article EN cc-by Nature Genetics 2020-02-05
Esther Rheinbay Morten Muhlig Nielsen Federico Abascal Jeremiah A. Wala Ofer Shapira and 95 more Grace Tiao Henrik Hornshøj Julian M. Hess Randi Istrup Juul Ziao Lin Lars Feuerbach Radhakrishnan Sabarinathan Tobias Madsen Jaegil Kim Loris Mularoni Shimin Shuai Andrés Lanzós Carl Herrmann Yosef E. Maruvka Ciyue Shen Samirkumar B. Amin Pratiti Bandopadhayay Johanna Bertl Keith A. Boroevich John Busanovich Joana Carlevaro-Fita Dimple Chakravarty Calvin Wing Yiu Chan David Craft Priyanka Dhingra Klev Diamanti Nuno A. Fonseca Abel González-Pérez Qianyun Guo Mark P. Hamilton Nicholas J. Haradhvala Hong Chen Keren Isaev Todd A. Johnson Malene Juul André Kahles Abdullah Kahraman Young-Wook Kim Jan Komorowski Kiran Kumar Sushant Kumar Donghoon Lee Kjong-Van Lehmann Yilong Li Eric Minwei Liu Lucas Lochovsky Keunchil Park Oriol Pich Nicola D. Roberts Gordon Saksena Steven E. Schumacher Nikos Sidiropoulos Lina Sieverling Nasa Sinnott-Armstrong Chip Stewart David Tamborero José M. C. Tubío Husen M. Umer Liis Uusküla-Reimand Claes Wadelius Lina Wadi Xiaotong Yao Cheng‐Zhong Zhang Jing Zhang James E. Haber Asger Hobolth Marcin Imieliński Manolis Kellis Michael S. Lawrence Christian von Mering Hidewaki Nakagawa Benjamin J. Raphael Mark A. Rubin Chris Sander Lincoln D. Stein Joshua M. Stuart Tatsuhiko Tsunoda David A. Wheeler Rory Johnson Jüri Reimand Mark Gerstein Ekta Khurana Peter J. Campbell Núria López-Bigas Federico Abascal Samirkumar B. Amin Gary D. Bader Pratiti Bandopadhayay Jonathan Barenboim Rameen Beroukhim Johanna Bertl Keith A. Boroevich Søren Brunak Peter J. Campbell Joana Carlevaro-Fita

The discovery of drivers cancer has traditionally focused on protein-coding genes

10.1038/s41586-020-1965-x article EN cc-by Nature 2020-02-05
Bernardo Rodríguez–Martín Eva G. Álvarez Adrian Baez‐Ortega Jorge Zamora Fran Supek and 95 more Jonas Demeulemeester Martín Santamarina Young Seok Ju Javier Temes Daniel García‐Souto Harald Detering Yilong Li Jorge Rodríguez‐Castro Ana Dueso-Barroso Alicia L. Bruzos Stefan C. Dentro Miguel G. Blanco Gianmarco Contino Daniel Ardeljan Marta Tojo Nicola D. Roberts Sonia Zumalave Paul A. Edwards Joachim Weischenfeldt Montserrat Puiggròs Zechen Chong Ken Chen Eunjung Alice Lee Jeremiah A. Wala Keiran Raine Adam P. Butler Sebastian M. Waszak Fábio C. P. Navarro Steven E. Schumacher Jean Monlong Francesco Maura Niccolò Bolli Guillaume Bourque Mark Gerstein Peter J. Park David C. Wedge Rameen Beroukhim David Torrents Jan O. Korbel Iñigo Martincorena Rebecca C. Fitzgerald Peter Van Loo Haig H. Kazazian Kathleen H. Burns Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martínez-Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs

Abstract About half of all cancers have somatic integrations retrotransposons. Here, to characterize their role in oncogenesis, we analyzed the patterns and mechanisms retrotransposition 2,954 cancer genomes from 38 histological subtypes within framework Pan-Cancer Analysis Whole Genomes (PCAWG) project. We identified 19,166 somatically acquired events, which affected 35% samples spanned a range event types. Long interspersed nuclear element (LINE-1; L1 hereafter) insertions emerged as first...

10.1038/s41588-019-0562-0 article EN cc-by Nature Genetics 2020-02-05

Abstract Ionizing radiation is a potent carcinogen, inducing cancer through DNA damage. The signatures of mutations arising in human tissues following vivo exposure to ionizing have not been documented. Here, we searched for 12 radiation-associated second malignancies different tumour types. Two somatic mutation characterize irrespective type. Compared with 319 radiation-naive tumours, tumours carry median extra 201 deletions genome-wide, sized 1–100 base pairs often microhomology at the...

10.1038/ncomms12605 article EN cc-by Nature Communications 2016-09-12
Kadir C. Akdemir Victoria T. Le Sahaana Chandran Yilong Li Roel G.W. Verhaak and 95 more Rameen Beroukhim Peter J. Campbell Lynda Chin Jesse R. Dixon P. Andrew Futreal Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martínez-Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nicholas D. Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour Malik Alawi Monique Albert Kenneth Aldape Ludmil B. Alexandrov Adrian Ally

Chromatin is folded into successive layers to organize linear DNA. Genes within the same topologically associating domains (TADs) demonstrate similar expression and histone-modification profiles, boundaries separating different have important roles in reinforcing stability of these features. Indeed, domain disruptions human cancers can lead misregulation gene expression. However, frequency remains unclear. Here, as part Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium International...

10.1038/s41588-019-0564-y article EN cc-by Nature Genetics 2020-02-05

Looping together genes in cancer A subset of human cancers are characterized by aberrant fusion two specific genes. In some cases, the activity resultant protein drives tumor growth. Most appear to arise from simple reciprocal chromosomal translocations. Anderson et al. found that characteristic gene a bone and soft tissue called Ewing sarcoma is produced far more complicated mechanism (see Perspective Imielinski Ladanyi). nearly half tumors examined, was created formation dramatic genomic...

10.1126/science.aam8419 article EN Science 2018-08-30

Abstract The major genetic determinants of cutaneous melanoma risk in the general population are disruptive variants ( R alleles) melanocortin 1 receptor MC1R ) gene. These alleles also linked to red hair, freckling, and sun sensitivity, all which known phenotypic factors. Here we report that melanomas for somatic C>T mutations, a signature exposure, expected single-nucleotide variant count associated with presence an allele is estimated be 42% (95% CI, 15–76%) higher than among persons...

10.1038/ncomms12064 article EN cc-by Nature Communications 2016-07-12
Lina Sieverling Chen Hong Sandra D. Koser Philip Ginsbach Kortine Kleinheinz and 95 more Barbara Hutter Delia M. Braun Isidro Cortés‐Ciriano Ruibin Xi Rolf Kabbe Peter J. Park Roland Eils Matthias Schlesner Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martínez-Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nicholas D. Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Benedikt Brors Karsten Rippe David Jones Lars Feuerbach Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung-Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir

Abstract Cancers require telomere maintenance mechanisms for unlimited replicative potential. They achieve this through TERT activation or alternative lengthening associated with ATRX DAXX loss. Here, as part of the ICGC/TCGA Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium , we dissect whole-genome sequencing data over 2500 matched tumor-control samples from 36 different tumor types aggregated within to characterize genomic footprints these mechanisms. While content tumors mutations...

10.1038/s41467-019-13824-9 article EN cc-by Nature Communications 2020-02-05

With the advent of relatively affordable high-throughput technologies, DNA sequencing cancers is now common practice in cancer research projects and will be increasingly used clinical to inform diagnosis treatment. Somatic (cancer-only) single nucleotide variants (SNVs) are simplest class mutation, yet their identification data confounded by germline polymorphisms, tumour heterogeneity analysis errors. Four recently published algorithms for detection somatic SNV sites matched cancer-normal...

10.1093/bioinformatics/btt375 article EN cc-by Bioinformatics 2013-07-09

ABSTRACT A key mutational process in cancer is structural variation, which rearrangements delete, amplify or reorder genomic segments ranging size from kilobases to whole chromosomes. We developed methods group, classify and describe variants, applied >2,500 genomes. Nine signatures of variation emerged. Deletions have trimodal distribution; assort unevenly across tumour types patients; enrich late-replicating regions; correlate with inversions. Tandem duplications also distribution, but...

10.1101/181339 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2017-08-27

Whether cell types exposed to a high level of environmental insults possess type-specific prosurvival mechanisms or enhanced DNA damage repair capacity is not well understood. BRN2 tissue-restricted POU domain transcription factor implicated in neural development and several cancers. In melanoma, plays key role promoting invasion regulating proliferation. Here we found, surprisingly, that rather than interacting with cofactors, instead associated response proteins directly binds PARP1...

10.1101/gad.314633.118 article EN Genes & Development 2019-02-25

Abstract Cancer cells can acquire profound alterations to the structure of their genomes, including rearrangements that fuse distant DNA breakpoints. We analyze distribution somatic across cancer genome, using whole-genome sequencing data from 2,693 tumor-normal pairs. observe substantial variation in density rearrangement breakpoints, with enrichment open chromatin and sites high densities repetitive elements. After accounting for these patterns, we identify significantly recurrent...

10.1101/187609 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2017-09-14

Abstract About half of all cancers have somatic integrations retrotransposons. To characterize their role in oncogenesis, we analyzed the patterns and mechanisms retrotransposition 2,954 cancer genomes from 37 histological subtypes. We identified 19,166 somatically acquired events, affecting 35% samples, spanning a range event types. L1 insertions emerged as first most frequent type structural variation esophageal adenocarcinoma, second head-and-neck colorectal cancers. Aberrant can delete...

10.1101/179705 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2017-08-24

10.1016/0968-0004(80)90035-3 article EN Trends in Biochemical Sciences 1980-10-01
Coming Soon ...